Myomo welcomes Heather Getz to its Board of Directors

– USA, MA –  Myomo, Inc. (NYSE American: MYO), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of Heather Getz to its Board of Directors effective March 26, 2024, bringing the Board to seven members.

“We welcome Heather to the Myomo board of directors. She brings financial and operational experience in scaling medical device and technology companies, which will be valuable to the board of directors as Myomo accelerates its growth,” said Chairman and CEO, Paul Gudonis.

Heather Getz will also join the audit committee as its chair.

About Heather Getz

Heather Getz brings more than 25 years of corporate experience creating long-term value through financial, general management, and healthcare leadership. She has significant expertise in finance, reimbursement, investor relations, compliance, M&A, and strategic planning.

Heather Getz currently holds the position of EVP and CFOO of Butterfly Network Inc. (NYSE: BFLY), a digital health company that is transforming care with handheld, whole-body ultrasound. For the 12 years before Butterfly Network, Ms. Getz was CFAO of BioTelemetry where she was responsible for all aspects of company financial, investor relations, human relations, legal, and compliance functions, and worked extensively in strategic planning. She has also held leadership positions at VIASYS Healthcare, Alita Pharmaceuticals, and

“I am excited to join the Myomo board at such a pivotal time in the company’s history. I am very impressed by the technology and how it has been used to restore function in the paralyzed or weakened arms and hands of individuals that have suffered injury so that they can return to work, live independently and reduce their cost of care,” said Heather Getz. “I look forward to working with the team to further accelerate the company’s already impressive growth.”

Ms. Getz holds a Master of Business Administration and a Bachelor’s degree in Accountancy from Villanova University. She is a certified public accountant and a member of the American Institute of Certified Public Accountants, the Pennsylvania Institute of CPAs, the National Investor Relations Institute, and the National Association for Corporate Directors.

About Myomo

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. Myomo develops and markets the MyoPro product line. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS, or other neuromuscular disease or injury. It is currently the only marketed device in the U.S. that, senses a patient’s own EMG signals through non-invasive sensors on the arm, which can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects, and doing household tasks. Many can return to work, live independently, and reduce their cost of care. Myomo is headquartered in Boston, Massachusetts, with sales and clinical professionals across the U.S. and representatives internationally.


- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.